Cerebral and Peripheral Perfusion Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Alzheimer's Disease
Interventions
DRUG

atorvastatin

40mg daily for 4 months

DRUG

Placebo

Matching placebo daily for 4 months

Trial Locations (1)

53705

Karen Lazar, Madison

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00751907 - Cerebral and Peripheral Perfusion Pilot Study | Biotech Hunter | Biotech Hunter